Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,230.00    -160.00 (-2.97%)
Bid:
5,195.00
Ask:
5,205.00
Spread: 10.00 (0.192%)
Market Cap: £3.80b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Board Changes

8 Apr 2026 07:00

RNS Number : 5405Z
Renishaw PLC
08 April 2026
 

Board Changes

 

Renishaw plc ("Company"), a leading provider of manufacturing technologies, analytical instruments and medical devices, announces the following changes to its Board of Directors ("Board").

 

 

Appointment of Chief Financial Officer

 

The Company is pleased to announce that following a comprehensive search process the Board has appointed John Shipsey as Chief Financial Officer ("CFO") and Executive Director with effect from 13 April 2026. 

 

John comes with significant Board and Executive Leadership experience, having undertaken the role of CFO in various companies in the listed and private setting, including 12 years at Dyson Limited, 5 years at Smiths Group plc and 2 years at Featurespace Limited. John also held finance and strategy roles at Diageo plc earlier in his career and served as a Non-executive Director of Dechra Pharmaceuticals PLC.

 

Sir David Grant, Interim Chair, commented "I would like to warmly welcome John to Renishaw and its Board. John brings a deep understanding of the industrials sector and its associated performance drivers. He has a strong track record of leading high-performing finance functions, and we look forward to him strengthening both the Board and Executive Leadership team."

 

 

Appointment of Chair

 

The Company also announces that the Board has decided to appoint Sir David Grant as its permanent Chair with immediate effect for a period of up to two years. The Board considers that Sir David has consistently demonstrated the competencies and leadership required of the Chair and his permanent appointment is in the best interests of the Company and its shareholders at this time. Sir David will retain his role as Chair of the Nomination Committee.

 

The search process for the Company's next Chair will continue with the aim of making an appointment by 2028. The Company is also continuing its search for an additional Independent Non-executive Director.

 

 

Appointment of Senior Independent Director

 

Following the appointment of Chair, the Company is also pleased to announce that Juliette Stacey has been appointed to the role of Senior Independent Director with immediate effect. Juliette was originally appointed as an Independent Non-executive Director of the Company on 1 January 2022 and has been Chair of the Audit Committee and served as a member of the Nomination and Remuneration Committees since her appointment.

 

There is no further information to be disclosed for the purposes of UK Listing Rule 6.4.8R.

 

Kasim Hussain

Group General Counsel & Company Secretary

8 April 2026

 

 

 

Renishaw plc

Registered office:

New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number:

01106260, England and Wales

Telephone:

+44 (0)1453 524524

Website:

www.renishaw.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKDLFBQZLEBBD
Date   Source Headline
25th Jul 20182:00 pmRNSDirectorate Change
4th Jul 20187:00 amRNSNotice of Results
13th Jun 20181:00 pmRNSDirector Declaration
24th May 20183:00 pmRNSVoting Arrangement
9th May 20187:00 amRNSTrading Statement
23rd Apr 20182:00 pmRNSDirector Declaration
9th Apr 20188:42 amRNSDirector/PDMR Shareholding
19th Mar 201812:00 pmRNSNotice of Investor Day
26th Jan 20181:27 pmRNSDirector/PDMR Shareholding
25th Jan 20185:03 pmRNSDirector/PDMR Shareholding
25th Jan 20187:00 amRNSHalf-year Report
24th Jan 20183:12 pmRNSChange in Directors' Responsibilities
11th Jan 20187:00 amRNSNotice of Results
20th Oct 20172:20 pmRNSResult of AGM
25th Aug 20177:00 amRNSAnnual Financial Report and Directorate Change
27th Jul 20177:00 amRNSFinal Results
10th Jul 201711:00 amRNSNotice of Results
26th May 20177:00 amRNSRemuneration policy 2017
10th May 20177:00 amRNSTrading Statement
31st Mar 20179:00 amRNSNotice of Investor Day
26th Jan 20177:00 amRNSHalf-year Report
9th Jan 201710:00 amRNSNotice of Results
13th Oct 20163:20 pmRNSResult of AGM
13th Oct 201610:54 amRNSTrading Statement
26th Aug 20169:00 amRNSAnnual Financial Report
27th Jul 20167:00 amRNSFinal Results
7th Jul 201610:00 amRNSNotice of Results
11th May 20167:00 amRNSTrading Statement
24th Mar 20167:00 amRNSTrading Statement
23rd Mar 201610:00 amRNSDate of Investor Day
25th Feb 20162:52 pmRNSDisclosure of Home Member State
28th Jan 20167:00 amRNSHalf Yearly Report
13th Jan 20161:39 pmRNSNotice of Results
15th Dec 20152:11 pmRNSDirector - change in responsibilities
15th Oct 20154:59 pmRNSResult of AGM
15th Oct 201510:31 amRNSTrading Statement
28th Aug 20157:00 amRNSAnnual Financial Report
29th Jul 20157:00 amRNSFinal Results
15th Jul 20152:06 pmRNSNotice of Results
18th May 201511:04 amRNSDirector/PDMR Shareholding
13th May 20157:00 amRNSTrading Statement
17th Mar 20157:43 amRNSDate of Investor day
29th Jan 20157:00 amRNSHalf Yearly Report
13th Jan 20153:08 pmRNSNotice of Results
6th Jan 20154:14 pmRNSTrading Statement
17th Nov 20147:00 amRNSStatement re Relationship agreement
11th Nov 20147:00 amRNSTrading Statement
27th Oct 20147:00 amRNSTrading Statement
16th Oct 20142:55 pmRNSResult of AGM
16th Oct 201410:04 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.